MedPath

Raloxifene Hydrochloride

These highlights do not include all the information needed to use raloxifene hydrochloride tablets, USP safely and effectively. See full prescribing information for raloxifene hydrochloride tablets, USP. Raloxifene Hydrochloride Tablets, USP for Oral Use Initial U.S. Approval: 1997

Approved
Approval ID

2b94ecf5-d870-4132-b455-d5ee5c9dce56

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 30, 2020

Manufacturers
FDA

Exelan Pharmaceuticals, Inc.

DUNS: 967795266

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Raloxifene Hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code76282-256
Application NumberANDA090842
Product Classification
M
Marketing Category
C73584
G
Generic Name
Raloxifene Hydrochloride
Product Specifications
Route of AdministrationORAL
Effective DateAugust 26, 2019
FDA Product Classification

INGREDIENTS (11)

CROSPOVIDONEInactive
Code: 2S7830E561
Classification: IACT
POLOXAMER 407Inactive
Code: TUF2IVW3M2
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
HYPROMELLOSE 2910 (3 MPA.S)Inactive
Code: 0VUT3PMY82
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
POLYETHYLENE GLYCOL 400Inactive
Code: B697894SGQ
Classification: IACT
POLYSORBATE 80Inactive
Code: 6OZP39ZG8H
Classification: IACT
RALOXIFENE HYDROCHLORIDEActive
Quantity: 60 mg in 1 1
Code: 4F86W47BR6
Classification: ACTIB
HYDROXYPROPYL CELLULOSE, UNSPECIFIEDInactive
Code: 9XZ8H6N6OH
Classification: IACT
MANNITOLInactive
Code: 3OWL53L36A
Classification: IACT
HYPROMELLOSE 2910 (6 MPA.S)Inactive
Code: 0WZ8WG20P6
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Raloxifene Hydrochloride - FDA Drug Approval Details